A C3 convertase assay for nephritic factor functional activity

被引:18
|
作者
Jelezarova, E
Schlumberger, M
Sadallah, S
Späth, PJ
Schifferli, JA
Lutz, HU [1 ]
机构
[1] ETH Zentrum, Swiss Fed Inst Technol, Inst Biochem, CH-8092 Zurich, Switzerland
[2] Univ Basel Hosp, Dept Med, CH-4031 Basel, Switzerland
[3] SRC, ZLB Cent Lab, Blood Transfus Serv, Bern, Switzerland
关键词
C3 nephritic factor; C3; convertase; complement; C3b(2)-IgG;
D O I
10.1016/S0022-1759(01)00295-2
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
C3 nephritic factor (C3NeF) is an autoantibody against the C3 convertase which stabilizes this otherwise inherently labile neoenzyme and induces a continuous activation of the alternative pathway with C3 depletion. NeF is found in patients with membranoproliferative glomerulonephritis and/or partial lipodystrpohy. NeF activity is usually detected in plasma by hemolytic tests. In order to obtain reproducible data for the functional activity of purified C3NeF IgG a solid phase assay was developed. C3 convertase was generated on immobilized C3b by incubation with factors B and D in the presence of Ni2+. Convertase sites were left to decay in the presence of normal IgG or NeF IgG. Residual convertase activity was measured by adding I-125-C3 and capturing nascent I-125-C3b on the plate surface via covalently coupled NH2-Glu-Tyr dipeptide, In the presence of factor H during C3 convertase decay, a dose dependent stabilizing activity was shown for NeF IgG including NeF IgG purified from urine. A second format of the assay was developed in which C3 convertase was assembled on C3b(2)-IgG complexes in the presence of Mg2+. Since these complexes are more efficient as convertase precursors the signal was five-fold higher than with C3b. Convertase decay, on the other hand, was not influenced by the nature of the precursor and in both systems the stabilizing activity of NeF IgG was similar. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:45 / 52
页数:8
相关论文
共 50 条
  • [21] C4 nephritic factor in C3 glomerulopathy
    Zhang, Yuzhou
    Nester, Carla M.
    Smith, Richard J. H.
    MOLECULAR IMMUNOLOGY, 2014, 61 (02) : 227 - 227
  • [22] C3 NEPHRITIC FACTOR AND MEMBRANOPROLIFERATIVE NEPHRITIS - CORRELATION OF SERUM LEVELS OF NEPHRITIC FACTOR WITH C3 LEVELS, WITH THERAPY, AND WITH PROGRESSION OF DISEASE
    VALLOTA, EH
    WEST, CD
    FORRISTAL, J
    DAVIS, NC
    JOURNAL OF PEDIATRICS, 1972, 80 (06): : 947 - +
  • [23] REACTION-MECHANISMS OF C3 NEPHRITIC FACTOR
    SISSONS, JGP
    AMOS, N
    PETERS, DK
    CLINICAL SCIENCE AND MOLECULAR MEDICINE, 1976, 50 (02): : P12 - P12
  • [24] SEARCH FOR THE NEPHRITIC FACTOR (C3 NEF) IN SERUM
    MAILLET, F
    KAZATCHKINE, M
    PRESSE MEDICALE, 1991, 20 (23): : 1090 - 1091
  • [25] C3 Glomerulonephritis with Nephritic Factor Treated with Rituximab
    Sawaf, Hanny
    Nakhoul, Georges
    Mehdi, Ali
    Taliercio, Jonathan J.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 461 - 461
  • [26] C3 nephritic factor in a child with fever and hypocomplementemia
    Askenazi, N
    Singer, NG
    Gewurz, AT
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2001, 107 (02) : S273 - S273
  • [27] IGG SUBCLASS STUDIES OF C3 NEPHRITIC FACTOR
    DAVIS, AE
    GELFAND, EW
    SCHUR, PH
    ROSEN, FS
    ALPER, CA
    CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1978, 11 (01): : 98 - 101
  • [28] Hypocomplementaemia in a newborn caused by transplacental passage of maternal autoantibody with C3 nephritic factor (C3 NeF) activity
    Weiss, L
    Rougier, N
    Blouin, J
    Kazatchkine, MD
    Lhotta, K
    Konig, P
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1995, 10 (12) : 2374 - 2374
  • [29] URTICARIAL VASCULITIS - A PRESENTATION OF C3 NEPHRITIC FACTOR
    CARMICHAEL, AJ
    MARSDEN, JR
    BRITISH JOURNAL OF DERMATOLOGY, 1993, 128 (05) : 589 - 589
  • [30] C3 NEPHRITIC FACTOR (C3NEF) - STABILIZATION OF FLUID PHASE AND CELL-BOUND ALTERNATIVE PATHWAY CONVERTASE
    DAHA, MR
    FEARON, DT
    AUSTEN, KF
    JOURNAL OF IMMUNOLOGY, 1976, 116 (01): : 1 - 7